AVEFF
Price:
$0.0045
Market Cap:
$73.41M
Avecho Biotechnology Limited is an Australian-based firm specializing in the development, production, and sale of various products. Central to its operations is the proprietary and patented Targeted Penetration Matrix (TPM) drug delivery system, which the company leverages across the pharmaceutical, skincare, animal health, and nutrition industries. Its product portfolio includes TPM and Vital ET, which are incorporated into drug delivery systems and cosmetic formulations. The company is also actively engaged in the development of TPM/Oxymorphone and TPM/Oxycodone. For human health, Avecho's offerings facilitate drug administration through diverse methods such as gels, injectables, and trans...[Read more]
Industry
Biotechnology
IPO Date
2018-08-24
Stock Exchange
OTC
Ticker
AVEFF
According to Avecho Biotechnology Limited’s latest financial reports and current stock price. The company's current PE Ratio is -18.00. This represents a change of 1.01% compared to the average of -1.63 of the last 4 quarters.
The mean historical PE Ratio of Avecho Biotechnology Limited over the last ten years is -4.61. The current -18.00 PE Ratio has changed 38.98% with respect to the historical average. Over the past ten years (40 quarters), AVEFF's PE Ratio was at its highest in in the December 2011 quarter at 73.24. The PE Ratio was at its lowest in in the December 2006 quarter at -14.65.
Average
-4.61
Median
-2.57
Minimum
-17.06
Maximum
8.00
Discovering the peaks and valleys of Avecho Biotechnology Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 221.43%
Maximum Annual PE Ratio = 8.00
Minimum Annual Increase = -500.00%
Minimum Annual PE Ratio = -17.06
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -6.43 | 221.43% |
| 2024 | -2.00 | 0% |
| 2023 | -2.00 | -82.67% |
| 2022 | -11.54 | 46.15% |
| 2021 | -7.89 | -53.72% |
| 2020 | -17.06 | -313.24% |
| 2019 | 8.00 | -500.00% |
| 2018 | -2.00 | -34.00% |
| 2017 | -3.03 | 43.39% |
| 2016 | -2.11 | 179.53% |
The current PE Ratio of Avecho Biotechnology Limited (AVEFF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-3.48
5-year avg
-5.97
10-year avg
-4.61
Avecho Biotechnology Limited’s PE Ratio is less than Living Cell Technologies Limited (-11.54), less than Eiger BioPharmaceuticals, Inc. (-0.17), less than Ceapro Inc. (-3.74), less than Poxel S.A. (-0.53), less than Antibe Therapeutics Inc. (-0.80), less than Bionomics Limited (-0.35), less than LexaGene Holdings Inc. (0), less than Verici Dx plc (-0.38), less than Nuvo Pharmaceuticals Inc. (0), less than Rapid Dose Therapeutics Corp. (-3.16),
| Company | PE Ratio | Market cap |
|---|---|---|
| -11.54 | $11.39M | |
| -0.17 | $12.59M | |
| -3.74 | $13.31M | |
| -0.53 | $16.14M | |
| -0.80 | $11.43M | |
| -0.35 | $8.81M | |
| 0 | $11.34M | |
| -0.38 | $5.01M | |
| 0 | $11.15M | |
| -3.16 | $9.28M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Avecho Biotechnology Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Avecho Biotechnology Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Avecho Biotechnology Limited's PE Ratio?
How is the PE Ratio calculated for Avecho Biotechnology Limited (AVEFF)?
What is the highest PE Ratio for Avecho Biotechnology Limited (AVEFF)?
What is the 3-year average PE Ratio for Avecho Biotechnology Limited (AVEFF)?
What is the 5-year average PE Ratio for Avecho Biotechnology Limited (AVEFF)?
How does the current PE Ratio for Avecho Biotechnology Limited (AVEFF) compare to its historical average?